Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
While diabetes is a well-known risk factor, there are other risk factors that may increase the risk of gastroparesis, added Hanna, who said that includes obesity, being female and nervous system diseases including Parkinsons disease or multiple sclerosis
There may be more research being done on Gila Monster saliva due to its chemical complexities and its history in helping to produce a novel drug to help with type 2 diabetes
Sources MOUNJARO TM (Tirzepatide) Injection, for Subcutaneous Use. Access Data FDA , Food and Drug Administration, Accessed 06 May 2024
Many people lose significant amounts of subcutaneous fat on GLP-1 medications while their visceral stores remain relatively intact
